Kurvelo NDC 50090-6374

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-6374Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-6374Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-6374-0	50090637400	1 KIT in 1 CARTON (50090-6374-0) * 21 TABLET in 1 BLISTER PACK (68180-841-74) * 7 TABLET in 1 BLISTER PACK (68180-842-74)Marketed from Feb 20, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Kurvelo
Generic name (nonproprietary): levonorgestrel and ethinyl estradiol
Dosage form: Kit
Labeler: A-S Medication Solutions
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091408
Marketing start: Feb 7, 2021
Listing expires: Dec 31, 2026
Identifiers: Product ID 50090-6374_1529b388-2aad-440d-8b01-a40291c834baSPL ID 1529b388-2aad-440d-8b01-a40291c834baSPL set ID 51e4270a-1b91-4ff8-9a50-ffe49204b6b4RxCUI 238019, 748797, 748878, 1356074

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N450090637400 followed by a unit qualifier and the quantity

Package 50090-6374-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 21, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Kurvelo is indicated for use by females of reproductive potential to prevent pregnancy.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 091408

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091408
Product	Strength	Form · route	Labeler	Product NDC
Kurvelolevonorgestrel and ethinyl estradiol	—	Kit	Lupin Pharmaceuticals, Inc.	68180-844